untitled design

Sputnik-V: The “technological differences” between Russia and the EMA remain

The Kremlin hopes that the Russian coronavirus vaccine will soon receive its approval European Medicines Agency (Coreper), considering, in fact, that the approval should have been given a long time ago, said on Thursday the representative of the Russian president Dmitry Peshkov, acknowledging that there are some technological differences with the EMA regarding certification Sputnik-V.

“Indeed, there are some technological differences regarding the completeness of the documents and data submitted to certify our vaccine by the respective European Medicines Agency,” said Peshkov, noting that “the European some data is missing».

At the same time, he stated that the Ministry of Health and other competent authorities, such as the Russian Direct Investment Fund (RDIF), are dealing with this issue and that purely technical nature, formal procedures“, As broadcast by APE BPE.

Russia completes the bureaucratic procedures required to complete the certification of the Sputnik-V vaccine by the European Medicines Agency (EMA), the RIA news agency reported, citing the Russian Ministry of Health, adding that it expects an EMA mission to the country this year. .

The European Medicines Agency (Coreper) is unlikely to decide whether to approve Sputnik V until at least its first quarter 2022, because some data required for the review are still missing, a source familiar with the matter told Reuters.

It is reminded that and on the part of the WHO The process of approving the Russian vaccine has been “frozen”.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular